|
Home
>
Newsletters
> May 23, 2013
FDAnews Device Daily Bulletin
May 23, 2013
| Vol.
10 No.
102
Goldman Sachs last week announced plans to invest about $20 million in Indian devicemaker BPL Medical Technologies, marking one of the largest medtech investments made to date in an emerging market.
Deborah Autor, U.S. Food and Drug Administration deputy commissioner for global regulatory operations and policy, is leaving to join the regulatory policy team at generic drugmaker Mylan.
Israeli entrepreneur Leon Eisen has created Oxitone, a watch-like device that can detect blood oxygen levels and heart rate by the minute.
University of Washington scientists have created a hydrogel that can block the body from producing a natural response to the implantation of a foreign object.
Neuronetics has come out with data that support its NeuroStar TMS Therapy System as effective against depression that has not responded to other methods of treatment.
The Catskill Regional Medical Center is informing patients who received insulin injections with an insulin pen between 2007 and 2013 that they may have received injections from a previously-used device.
ALung is going after Chinese regulatory approval for its Hemolung breathing assist device.
Germany has seized almost 200 stents from Boston Scientific over a patent infringement issue in the Dusseldorf court system.
|
Register Now
Archives
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.